Benchmark initiated coverage on Quipt Home Medical with a new price target
$QIPT
Misc Health and Biotechnology Services
Health Care
Benchmark initiated coverage of Quipt Home Medical with a rating of Buy and set a new price target of $7.50
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/17/2024 | Mkt Perform → Underperform | Raymond James | |
| 2/16/2024 | Outperform → Mkt Perform | Raymond James | |
| 6/14/2023 | $11.00 | Buy | Canaccord Genuity |
| 10/20/2021 | $7.50 | Buy | The Benchmark Company |
| 10/20/2021 | $7.50 | Buy | Benchmark |
4 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
3 - Quipt Home Medical Corp. (0001540013) (Issuer)
Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform
Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform
Canaccord Genuity resumed coverage of Quipt Home Medical with a rating of Buy and set a new price target of $11.00
CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme
CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio
4 - Quipt Home Medical Corp. (0001540013) (Issuer)
CINCINNATI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal year 2025 financial results and operational highlights. These results pertain to the three months ended December 31, 2024 and are reported in U.S. Dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, February 11, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (844) 763-8274 or 1 (647) 484-8814. A live webcast of the call will be accessible via the Company's website at https:/
CINCINNATI, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal first quarter 2025 financial results on Monday, February 10, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, February 11, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (844) 763 8274International: 1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of the Com
Posts Strong Adjusted EBITDA Margin1 for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024 CINCINNATI, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2024 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2024 and are reported in U.S. Dollars. The Company no longer qualifies as a "foreign private issuer" as such term is defined in Rule 405 under the U.S. Securities Act of 1933, as ame
10-Q - Quipt Home Medical Corp. (0001540013) (Filer)
8-K - Quipt Home Medical Corp. (0001540013) (Filer)
8-K - Quipt Home Medical Corp. (0001540013) (Filer)
CINCINNATI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal year 2025 financial results and operational highlights. These results pertain to the three months ended December 31, 2024 and are reported in U.S. Dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, February 11, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (844) 763-8274 or 1 (647) 484-8814. A live webcast of the call will be accessible via the Company's website at https:/
CINCINNATI, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, acknowledges receipt of a notice from Philotimo Fund, LP, an entity affiliated with Kanen Wealth Management, LLC and David L. Kanen ("KWM"), purporting to provide notice of its intent to solicit proxies in support of four director candidates to the Company's Board of Directors (the "Board") in opposition to the Company's four director candidates to the Board. The Company remains steadfast in its mission to deliver long-term value to all shareholders. As part of the Company's ongoing commitment
CINCINNATI, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal first quarter 2025 financial results on Monday, February 10, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, February 11, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (844) 763 8274International: 1 (647) 484 8814 A live webcast of the call will be accessible via the investor section of the Com
SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)
SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)